ESR1 and breast cancer: AAVs carrying gRNAs (+ templates for homologous directed repair [HDR] as needed) introduced oncogenic alterations common in human ER+ breast cancer, producing tumors that express ER and PR, depend on estrogen signaling, and respond to endocrine therapy.